Cite
Galvin SG, Larraufie P, Kay RG, et al. Peptidomics of enteroendocrine cells and characterisation of potential effects of a novel preprogastrin derived-peptide on glucose tolerance in lean mice. Peptides. 2021;140:170532doi: 10.1016/j.peptides.2021.170532.
Galvin, S. G., Larraufie, P., Kay, R. G., Pitt, H., Bernard, E., McGavigan, A. K., Brant, H., Hood, J., Sheldrake, L., Conder, S., Atherton-Kemp, D., Lu, V. B., O'Flaherty, E. A. A., Roberts, G. P., Ämmälä, C., Jermutus, L., Baker, D., Gribble, F. M., & Reimann, F. (2021). Peptidomics of enteroendocrine cells and characterisation of potential effects of a novel preprogastrin derived-peptide on glucose tolerance in lean mice. Peptides, 140170532. https://doi.org/10.1016/j.peptides.2021.170532
Galvin, Sam G, et al. "Peptidomics of enteroendocrine cells and characterisation of potential effects of a novel preprogastrin derived-peptide on glucose tolerance in lean mice." Peptides vol. 140 (2021): 170532. doi: https://doi.org/10.1016/j.peptides.2021.170532
Galvin SG, Larraufie P, Kay RG, Pitt H, Bernard E, McGavigan AK, Brant H, Hood J, Sheldrake L, Conder S, Atherton-Kemp D, Lu VB, O'Flaherty EAA, Roberts GP, Ämmälä C, Jermutus L, Baker D, Gribble FM, Reimann F. Peptidomics of enteroendocrine cells and characterisation of potential effects of a novel preprogastrin derived-peptide on glucose tolerance in lean mice. Peptides. 2021 Jun;140:170532. doi: 10.1016/j.peptides.2021.170532. Epub 2021 Mar 17. PMID: 33744371; PMCID: PMC8121762.
Copy
Download .nbib